Your browser doesn't support javascript.
loading
Authors' Reply to: Do All Gliflozins Reduce Stroke in Patients with Type 2 Diabetes Mellitus and Impaired Renal Function?
Barkas, Fotios; Liberopoulos, Evangelos; Milionis, Haralampos.
Afiliação
  • Barkas F; Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, Stavrou Niarchou Avenue, Ioannina, Epirus, 45110 Ioannina, Greece.
  • Liberopoulos E; Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, Stavrou Niarchou Avenue, Ioannina, Epirus, 45110 Ioannina, Greece.
  • Milionis H; Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, Stavrou Niarchou Avenue, Ioannina, Epirus, 45110 Ioannina, Greece. Electronic address: hmilioni@uoi.gr.
J Stroke Cerebrovasc Dis ; 30(7): 105810, 2021 07.
Article em En | MEDLINE | ID: mdl-33888433
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acidente Vascular Cerebral / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acidente Vascular Cerebral / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article